Your Compass for Pharma Success

INVESTIGATION REPORT FOR PRESENCE OF HAIR FOLLICLE IN COMPRESSED TABLET

INVESTIGATION REPORT FOR PRESENCE OF HAIR FOLLICLE IN COMPRESSED TABLET
INVESTIGATION REPORT FOR PRESENCE OF HAIR FOLLICLE IN COMPRESSED TABLET

INVESTIGATION REPORT

Subject: Presence of Hair Follicle in Compressed Tablet

Product Name: Calcium Carbonate 500 mg and Vitamin D3 125 IU Tablet

Batch Number: PGH/T/25-008

Date of Incident: 23/07/25

Company Name: XXYYZZ

Location: AABBCC

1. Objective

To investigate and identify the root cause for the presence of a hair follicle in a compressed tablet of Calcium Carbonate 500 mg and Vitamin D3 125 IU (Batch No. PGH/T/25-008), and to propose corrective and preventive actions (CAPA) to eliminate recurrence of such foreign contamination.

Key Parameter of Below Page:

INVESTIGATION REPORT FOR PRESENCE OF HAIR FOLLICLE IN COMPRESSED TABLET

Find below pages for complete report

Key Parameter of Below Page:

INVESTIGATION REPORT FOR PRESENCE OF HAIR FOLLICLE IN COMPRESSED TABLET

Find below pages for complete report

Click the link to download word file copy of this document:
https://pharmaguidehub.com/product/investigation-report-for-presence-of-hair-follicle-in-compressed-tablet/

Key Parameter of Below Page:

INVESTIGATION REPORT FOR PRESENCE OF HAIR FOLLICLE IN COMPRESSED TABLET

Find below pages for complete report

Key Parameter of Below Page:

INVESTIGATION REPORT FOR PRESENCE OF HAIR FOLLICLE IN COMPRESSED TABLET

Find below pages for complete report

Key Parameter of Below Page:

INVESTIGATION REPORT FOR PRESENCE OF HAIR FOLLICLE IN COMPRESSED TABLET

Find below pages for complete report

Key Parameter of Below Page:

INVESTIGATION REPORT FOR PRESENCE OF HAIR FOLLICLE IN COMPRESSED TABLET

Find below pages for complete report

Click the link to download word file copy of this document:
https://pharmaguidehub.com/product/investigation-report-for-presence-of-hair-follicle-in-compressed-tablet/

YOU CAN ALSO READ:

INVESTIGATION REPORT FOR ASSAY FAILURE OBSERVATION DURING TESTING OF AMLODIPINE 10 MG TABLETS

PHASE 1 INVESTIGATION REPORT FOR ASSAY FAILURE IN AMLODIPINE TABLETS 10 MG

INVESTIGATION REPORT FOR HARDNESS FAILURE DURING IN-PROCESS CHECK AT COMPRESSION STAGE IN AMLODIPINE 10 MG TABLETS

INVESTIGATION REPORT FOR THE OBSERVATION OF BLACK PARTICLE IN COMPRESSED TABLET AFTER COMPRESSION

INVESTIGATION REPORT FOR WATER LEAKAGE FROM COMPRESSION ROOF

INVESTIGATION REPORT FOR LEAK TEST FAILURE OF BLISTER PACK

INVESTIGATION REPORT FOR WRONG BATCH CODING OBSERVED ON MONOCARTON DURING SECONDARY PACKING

INVESTIGATION REPORT FOR THE OBSERVATION OF A LIVE LIZARD IN THE TABLET QUARANTINE AREA

6M-Based Investigation on Tablet Chipping at Compression Stage

INVESTIGATION REPORT FOR RAW MATERIAL SPILLAGE DURING DISPENSING

INVESTIGATION REPORT FOR OBSERVATION OF FLY IN MANUFACTURING CORRIDOR

INVESTIGATION REPORT FOR LOWER YIELD AT COMPRESSION STAGE

STANDARD OPERATING PROCEDURE FOR THE HANDLING OF DEVIATIONS AND INCIDENTS

CORRECTIVE AND PREVENTIVE ACTION (CAPA)   IN PHARMACEUTICAL

Share this article
Shareable URL
Prev Post

PHASE 1 INVESTIGATION REPORT FOR ASSAY FAILURE IN AMLODIPINE TABLETS 10 MG

Next Post

INVESTIGATION REPORT FOR DISSOLUTION FAILURE IN TAMSULOSIN 4 MG PELLETS (PHASE 1)

Leave a Reply

Your email address will not be published. Required fields are marked *

Read next

Discover more from PharmaGuideHub

Subscribe now to keep reading and get access to the full archive.

Continue reading